Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 130.20K | 67.00K | 42.60K | 123.60K | 104.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.40K | 114.00K | 82.30K | 195.00K | 179.70K |
| Operating Income | -173.40K | -114.00K | -82.30K | -195.00K | -179.70K |
| Income Before Tax | 777.20K | -128.20K | 489.00K | -1.19M | 25.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 777.20K | -128.20K | 489.00K | -1.19M | 25.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 777.20K | -128.20K | 489.00K | -1.19M | 25.40K |
| EBIT | -173.40K | -114.00K | -82.30K | -195.00K | -179.70K |
| EBITDA | -- | -- | -- | -194.50K | -179.10K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Average Diluted Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |